↓ Skip to main content

Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer

Overview of attention for article published in JAMA Oncology, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (97th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
79 X users

Citations

dimensions_citation
65 Dimensions

Readers on

mendeley
47 Mendeley
Title
Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer
Published in
JAMA Oncology, September 2021
DOI 10.1001/jamaoncol.2021.2318
Pubmed ID
Authors

Heath Skinner, Chen Hu, Theodoros Tsakiridis, Rafael Santana-Davila, Bo Lu, Jeremy J. Erasmus, Anthony J. Doemer, Gregory M. M. Videtic, James Coster, Alex Xuezhong Yang, Richard Y. Lee, Maria Werner-Wasik, Philip E. Schaner, Steven E. McCormack, Benjamin T. Esparaz, Ronald C. McGarry, Jose Bazan, Timothy Struve, Rebecca Paulus, Jeffrey D. Bradley

Timeline
X Demographics

X Demographics

The data shown below were collected from the profiles of 79 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 47 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 47 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 4 9%
Student > Master 3 6%
Other 2 4%
Researcher 2 4%
Student > Bachelor 1 2%
Other 3 6%
Unknown 32 68%
Readers by discipline Count As %
Medicine and Dentistry 6 13%
Nursing and Health Professions 5 11%
Biochemistry, Genetics and Molecular Biology 3 6%
Sports and Recreations 1 2%
Unspecified 1 2%
Other 0 0%
Unknown 31 66%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 100. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2021.
All research outputs
#443,558
of 26,177,525 outputs
Outputs from JAMA Oncology
#723
of 3,420 outputs
Outputs of similar age
#10,636
of 425,670 outputs
Outputs of similar age from JAMA Oncology
#19
of 85 outputs
Altmetric has tracked 26,177,525 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,420 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 83.7. This one has done well, scoring higher than 78% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,670 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.